Click image to enlarge
Uncoated plates for immobilizing unlabeled capture antibodies
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Assay Development
,
Immunogenicity
|
|
|
Analyte(s)
|
|
IgG
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO SECTOR S 600MM
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120MM
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
|
|
|
Plate Type
|
|
96-well
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
|
RT
|
1 each
(10 each)
|
|
|
|
|
RT
|
1 each
(10 each)
|
|
|
|
|
2-8 °C
|
1 each
(50 μg)
|
|
|
|
|
2-8 °C
|
1 each
(50 μg)
|
|
|
|
|
2-8 °C
|
1 each
(50 μg)
|
|
|
|
|
≤-70 °C
|
2 each
(150 nmol)
|
|
|
|
|
RT
|
1 bottle
(200 mL)
|
|
|
|
MSD Blocker A
|
RT
|
1 bottle
(1 l)
|
|
|
|
|
RT
|
1 bottle
(2 g)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
1 bottle
(200 mL)
|
|
|
|
Title
|
Journal
|
Year
|
|
Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada
|
|
|
|
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
|
|
|
|
MSD-based assays facilitate a rapid and quantitative serostatus profiling for the presence of anti-AAV antibodies
|
|
|
|
Clinical Performance of Three Commercial and Two In-House Multiplex Assays for SARS-CoV-2 Antibody Detection in Dried Blood Spot Specimens
|
|
|
|
SARS-CoV-2 Nucleocapsid Plasma Antigen for Diagnosis and Monitoring of COVID-19
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Meso Scale Japan 株式会社